申请人:The General Hospital Corporation
公开号:US10881656B2
公开(公告)日:2021-01-05
The present invention is directed to HIF inhibitors and methods of preventing cell proliferation, reducing inflammation, and treating an angiogenic disease or disorders.
本发明涉及 HIF 抑制剂以及防止细胞增殖、减少炎症和治疗血管生成疾病或紊乱的方法。